JP2007254345A - Maillard reaction inhibitor, skin care preparation containing the same and food and beverage - Google Patents

Maillard reaction inhibitor, skin care preparation containing the same and food and beverage Download PDF

Info

Publication number
JP2007254345A
JP2007254345A JP2006080105A JP2006080105A JP2007254345A JP 2007254345 A JP2007254345 A JP 2007254345A JP 2006080105 A JP2006080105 A JP 2006080105A JP 2006080105 A JP2006080105 A JP 2006080105A JP 2007254345 A JP2007254345 A JP 2007254345A
Authority
JP
Japan
Prior art keywords
maillard reaction
reaction inhibitor
food
fruit
leaves
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006080105A
Other languages
Japanese (ja)
Other versions
JP5313436B2 (en
Inventor
Kazuhiro Suetsugu
一博 末次
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Naris Cosmetics Co Ltd
Original Assignee
Naris Cosmetics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naris Cosmetics Co Ltd filed Critical Naris Cosmetics Co Ltd
Priority to JP2006080105A priority Critical patent/JP5313436B2/en
Publication of JP2007254345A publication Critical patent/JP2007254345A/en
Application granted granted Critical
Publication of JP5313436B2 publication Critical patent/JP5313436B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To obtain a new Maillard reaction inhibitor having high safety and a skin care preparation and a food and beverage. <P>SOLUTION: The Maillard reaction inhibitor has high safety and a Maillard reaction inhibiting effect and comprises a plant extract selected from putamen of Ziziphus zizyphus (Rhamnaceae), Malva nut of MACJONG (Sterculia lychnophera), seed of Cucurbita moschata(Cucurbitaceae), leaf of Eucommia ulmoildes (Eucommiaceae), root of Salacia oblonga (Celastraceae) and leaf of Chimaphila umbellata. (L.) W. Barton (Pyrolaceae). The antiaging skin care preparation comprises the Maillard reaction inhibitor. The food and beverage each comprise the Maillard reaction inhibitor. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、タンパク質またはアミノ酸と還元糖との縮合反応であるメイラード反応を抑制するメイラード反応阻害剤であり、各種皮膚外用剤又は飲食品へ応用するものである。 The present invention is a Maillard reaction inhibitor that suppresses the Maillard reaction, which is a condensation reaction between a protein or amino acid and a reducing sugar, and is applied to various skin external preparations or foods and drinks.

メイラード反応は、アミノ酸、タンパク質等のN末端のアミノ基と還元糖が非酵素的に結合し、シッフ塩基を形成し、その後アマドリ転移により安定なアマドリ化合物を形成する。この蛋白質の非酵素的糖化に関する研究は、特に食品科学の分野では古くから行われおり、メイラード反応としてよく知られる現象である。アマドリ化合物は、温度、水分活性、pH、保存方法などの環境条件によりさらに化学的に分解を受け、その分解物が重合してAGE(advanced
glycosylation end products)を形成する。AGEは、蛍光を有し、褐色調を呈するため、この反応は褐色反応とよばれる。
In the Maillard reaction, an N-terminal amino group such as an amino acid or protein and a reducing sugar are non-enzymatically bound to form a Schiff base, and then a stable Amadori compound is formed by Amadori transfer. This research on non-enzymatic saccharification of proteins has been carried out for a long time, particularly in the field of food science, and is a phenomenon well known as the Maillard reaction. Amadori compounds are further chemically decomposed by environmental conditions such as temperature, water activity, pH, storage method, etc., and the decomposition products are polymerized to produce AGE (advanced
glycosylation end products). Since AGE has fluorescence and exhibits a brown tone, this reaction is called a brown reaction.

生体内の蛋白質においても糖の存在で、生理的にこれらとまったく同様な反応が生じていることが明らかにされるようになった。特に高血糖の持続している糖尿病患者においてはメイラード反応が亢進しており、臨床的にはヘモグロビン糖化度を測定して糖尿病コントロールの指標として広く用いられている。近年では本反応の結果生じる構造や機能の変化が糖尿病のみならず、高血糖を起因とする合併症(糖尿病神経障害、糖尿病網膜症、糖尿病腎症)や種々の病変、老化に深い関わりがあることが判明している。 It has been clarified that in the protein in the living body, the presence of sugar causes a physiologically similar reaction to these. Particularly in diabetic patients with persistent hyperglycemia, the Maillard reaction is enhanced, and clinically, it is widely used as an index for diabetes control by measuring the degree of hemoglobin glycation. In recent years, changes in structure and function resulting from this reaction are not only related to diabetes, but are also deeply related to complications (diabetic neuropathy, diabetic retinopathy, diabetic nephropathy), various lesions, and aging caused by hyperglycemia. It has been found.

メイラード反応の機構は、現在次のように理解されている。すなわち、まずタンパク質の遊離アミノ基をグルコース等の還元糖のアルデヒド基が求核反応によって攻撃し、シッフ塩基を形成する。このシッフ塩基は不安定であり、分子内電子転移反応を起こしてアマドリ転移生成物を形成し安定化する。次いで、アマドリ生成物は種々のデオキシオソンを生成し、更にタンパク質のアミノ基と反応を起こして重合体形成をひき起こす。最後に、この重合体形成によりタンパク質の溶解度が低下し、プロテアーゼの作用を受けにくくなり、多くは蛍光を発する褐変物質となるのである。 The mechanism of the Maillard reaction is now understood as follows. That is, first, the free amino group of a protein is attacked by the aldehyde group of a reducing sugar such as glucose by a nucleophilic reaction to form a Schiff base. This Schiff base is unstable and undergoes an intramolecular electron transfer reaction to form and stabilize an Amadori transfer product. The Amadori product then produces a variety of deoxyoxones and further reacts with protein amino groups to cause polymer formation. Finally, this polymer formation reduces the solubility of the protein, makes it less susceptible to the action of proteases, and many become browning substances that fluoresce.

現在すでに、このメイラード反応を阻害する物質がいくつか知られている。メイラード反応阻害活性を有する成分としては、アミノグアニジン、アミノプロピオニトリル、ペニシラミンなどが良く知られている。その他、尿素やグアニジン(特開昭62−249908号)、メチルトリシラノール等のケイ素化合物(特開昭62−249909号)、ベンゾフェノン類(特開平4−368320号)、黄ごんフラボノイド(特開平3−240725号)について、これらがメイラード反応阻害活性を有することが報告されている。しかし、アミノグアニジンやアミノプロピオニトリルは効果的には強いが、幼年期の動物がアミノプロピオニトリルを含むマメ科植物の花を食することによって、成長時に必要なコラーゲンなどの架橋を抑制し、奇形になる原因と考えられている。また、その他の化合物は、作用が弱く、実用化のために十分満足のゆくものではなかった。
特開昭62−249908号公報 特開昭62−249909号公報 特開平4−368320号公報 特開平3−240725号公報
At present, several substances that inhibit this Maillard reaction are known. As components having Maillard reaction inhibitory activity, aminoguanidine, aminopropionitrile, penicillamine and the like are well known. In addition, urea, guanidine (JP-A-62-249908), silicon compounds such as methyltrisilanol (JP-A-62-249909), benzophenones (JP-A-4-368320), yellow flavonoids (JP-A-6-238820) No. 3-240725) are reported to have Maillard reaction inhibitory activity. However, aminoguanidine and aminopropionitrile are strong in effect, but childhood animals eat legumes that contain aminopropionitrile, which suppresses the cross-linking of collagen and other substances necessary for growth. , Is considered the cause of malformation. In addition, other compounds have weak effects and are not sufficiently satisfactory for practical use.
JP-A-62-249908 JP-A-62-249909 JP-A-4-368320 JP-A-3-240725

新規で安全性の高いメイラード反応阻害剤、更に皮膚外用剤又は飲食品を提供することを課題とする。 It is an object of the present invention to provide a new and highly safe Maillard reaction inhibitor, and a skin external preparation or food and drink.

本発明者らは、食用の経験がある植物抽出物の調査を行い、ナツメ(Ziziphus zizyphus(Rhamnaceae))の果核(酸棗仁)、MACJONG(Sterculia lychnophora)の果実(Malva nuts)、カボチャ(Cucurbita moschata(Cucurbitaceae))の種子、トチュウ(Eucommia
ulmoildes(Eucommiaceae))の葉、サラシア(Salacia oblonga(Celastraceae))の根、オオウメガサソウ(Chimaphila umbellata (L.) W. Barton(Pyrolaceae))の葉から得られる植物抽出物にペントシジンの生成すなわちメイラード反応を阻害し、肌の硬化、しわ形成、はり・つやの喪失の原因となるコラーゲンの架橋形成や、肌の黄くすみの原因となる着色を抑制し、皮膚老化防止効果や美肌効果において優れた性質を示すことを見い出した。
The present inventors have investigated plant extracts with edible experience, and found the fruit nuclei of jujube (Ziziphus zizyphus (Rhamnaceae)), the fruit of MACJONG (Sterculia lychnophora) (Malva nuts), the pumpkin (Cucurbita). Seeds of moschata (Cucurbitaceae), Eucommia
Pentosidine formation or Maillard reaction in plant extracts obtained from leaves of ulmoildes (Eucommiaceae), roots of Salacia oblonga (Celastraceae) and leaves of Chimaphila umbellata (L.) W. Barton (Pyrolaceae) Inhibits skin hardening, wrinkle formation, collagen cross-linking, which causes loss of elasticity and gloss, and suppresses coloring that causes yellowing of skin, and has excellent properties in preventing skin aging and beautifying skin. I found out to show.

すなわち、ナツメ(Ziziphus zizyphus(Rhamnaceae))の果核(酸棗仁)、MACJONG(Sterculia lychnophora)の果実(Malva nuts)、カボチャ(Cucurbita moschata(Cucurbitaceae))の種子、トチュウ(Eucommia
ulmoildes(Eucommiaceae))の葉、サラシア(Salacia oblonga(Celastraceae))の根、オオウメガサソウ(Chimaphila umbellata (L.) W. Barton(Pyrolaceae))の葉から得られる植物抽出物を利用することにより、皮膚のシワやタルミのような皮膚の形態変化、皮膚のくすみの予防又はその改善が期待できる。つまり、皮膚老化防止作用を持ち、且つ安全な皮膚外用剤又は飲食品を提供することをもって、本発明を完成するに至った。以下に本発明に至る経過を説明する。
That is, fruit kernels of jujube (Ziziphus zizyphus (Rhamnaceae)), MACJONG (Sterculia lychnophora) fruits (Malva nuts), pumpkin (Cucurbita moschata (Cucurbitaceae)) seeds, Eucommia
By using plant extracts obtained from leaves of ulmoildes (Eucommiaceae), roots of Salacia oblonga (Celastraceae), leaves of Chimaphila umbellata (L.) W. Barton (Pyrolaceae) It can be expected to prevent or improve skin morphological changes such as wrinkles and tarmi. That is, the present invention has been completed by providing a skin external preparation or a food or drink that has a skin aging preventing effect and is safe. The process leading to the present invention will be described below.

本発明のナツメ(Ziziphus zizyphus(Rhamnaceae))の果核(酸棗仁)、MACJONG(Sterculia lychnophora)の果実(Malva nuts)、カボチャ(Cucurbita moschata(Cucurbitaceae))の種子、トチュウ(Eucommia
ulmoildes(Eucommiaceae))の葉、サラシア(Salacia oblonga(Celastraceae))の根、オオウメガサソウ(Chimaphila umbellata (L.) W. Barton(Pyrolaceae))の葉の抽出物を含有した皮膚外用剤は、安全であり、生体内で生成するメイラード反応を抑えることにより、皮膚に対しては皮膚の硬化、しわ形成、はり喪失や、肌のくすみを抑制して、優れた皮膚老化防止効果、美肌効果を示す。また、ナツメ(Ziziphus zizyphus(Rhamnaceae))の果核(酸棗仁)、MACJONG(Sterculia lychnophora)の果実(Malva nuts)、カボチャ(Cucurbita moschata(Cucurbitaceae))の種子、トチュウ(Eucommia
ulmoildes(Eucommiaceae))の葉、サラシア(Salacia oblonga(Celastraceae))を含有した飲食品は、安全であり、生体内で生成するメイラード反応を抑えることにより、高血糖を起因とする合併症(糖尿病神経障害、糖尿病網膜症、糖尿病腎症)や種々の病変や老化を予防することが可能となった。
Nuts of the present invention (Ziziphus zizyphus (Rhamnaceae)) fruit nuclei (acid 棗仁), MACJONG (Sterculia lychnophora) fruits (Malva nuts), pumpkin (Cucurbita moschata (Cucurbitaceae)) seeds, Eucommia
Skin topical preparations containing extracts of leaves of ulmoildes (Eucommiaceae), roots of Salacia oblonga (Celastraceae), and leaves of Chimaphila umbellata (L.) W. Barton (Pyrolaceae) Yes, by suppressing the Maillard reaction generated in the living body, it suppresses skin hardening, wrinkle formation, loss of skin, and skin dullness, and exhibits excellent skin aging prevention effects and skin beautification effects. In addition, fruit kernels of jujube (Ziziphus zizyphus (Rhamnaceae)), MACJONG (Sterculia lychnophora) fruits (Malva nuts), pumpkin (Cucurbita moschata (Cucurbitaceae)) seeds, Eucommia
Foods and drinks that contain ulmoildes (Eucommiaceae) leaves and Salacia oblonga (Celastraceae) are safe and suppress the Maillard reaction that occurs in the body. Disorder, diabetic retinopathy, diabetic nephropathy) and various lesions and aging can be prevented.

発明実施の最良の形態BEST MODE FOR CARRYING OUT THE INVENTION

本発明で使用する「ナツメの果核(酸棗仁)」は、ナツメ(棗)はクロウメモドキ科ナツメ属の落葉高木で、果実を果物として、乾燥させ(乾しなつめ)、または菓子材料として食用にし、また漢方薬としても用いる。学名はZiziphus zizyphus またはZ. jujuba。英語ではJujubeまたはChinese date(中国のナツメヤシ)という。サネブトナツメまたはその近縁植物の実を乾燥したものは大棗(たいそう)、種子は酸棗仁(さんそうにん)と称する生薬である。(日本薬局方においては、大棗が収録され、ナツメの実とされている。)大棗には強壮作用・鎮静作用が有るとされる。甘味があり、補性作用・降性作用がある。生姜との組み合わせで、副作用の緩和などを目的に多数の漢方方剤に配合されている。酸棗仁には鎮静作用・催眠作用が有るとされる。酸味があり、補性作用・降性作用がある。酸棗仁湯などに配合されている。 As used in the present invention, a “jujube fruit kernel” is a deciduous tree of the genus Legume, which is a deciduous tree of the genus Oleaceae, dried as a fruit, or made edible as a confectionery material. Also used as a herbal medicine. The scientific name is Ziziphus zizyphus or Z. jujuba. In English, it is called Jujube or Chinese date. A dried herb of the sunflower jujube or its related plants is a herbal medicine called Taiho, and the seed is a soy sauce. (In the Japanese Pharmacopoeia, Daegu is recorded and dated.) Daegu is said to have tonic and sedative effects. It has sweetness and has complementary and descending effects. Combined with ginger, it is blended into many Chinese herbal medicines for the purpose of reducing side effects. It is said that acid soot has sedative and hypnotic effects. It has a sour taste and has complementary and descending effects. It is blended in sojujinto.

本発明に使用する「Malva nuts」とは、MACJONGとも呼ばれ、東南アジアで果実は食用とされる。コレステロールを抑え、ダイエットなどの作用があるとされる。 “Malva nuts” used in the present invention is also called MACJONG, and fruits are edible in Southeast Asia. It suppresses cholesterol and is said to have effects such as diet.

本発明に使用する「カボチャ」とは、ウリ科カボチャ属 Cucurbita に属する植物の総称であり、果実を食用とする。種子(パンプキンシード)も食品として市販されている。また、種子から取った食用油(パンプキンシードオイル)もある。 The “pumpkin” used in the present invention is a general term for plants belonging to the Cucurbita genus Cucurbita, and fruits are edible. Seeds (pumpkin seeds) are also commercially available as food. There is also edible oil (pumpkin seed oil) taken from seeds.

本発明に使用する「トチュウ」とは、中国原産のトチュウ科の落葉樹である。樹皮は医薬品として扱われる。葉は煎じて健康茶、杜仲茶として飲用される。杜仲茶は、グッタペルカという成分を含み、血圧の降下や肝機能の機能向上に効果があると言われている。また、薬性が穏かで補養強壮薬として用いられていて、応用される領域は広く、内科と産婦人科で見られる心臓、腎臓、生殖機能の衰退の症状には、いずれも良好な治療効果があるといわれる。更に、高血圧、高コレステリン血症、動脈硬化、脳神経衰弱などの心臓と脳中枢神経の疾病に有効であるといわれる。 The “eucommia” used in the present invention is a deciduous tree of Euphorbiaceae native to China. The bark is treated as a medicine. The leaves are decocted and used as health tea or Tochu tea. Tochu tea contains an ingredient called gutta percha and is said to be effective in lowering blood pressure and improving the function of liver function. It is moderately medicinal and is used as a tonic and is widely applied. Good treatments for the symptoms of heart, kidney and reproductive decline in internal medicine and obstetrics and gynecology. It is said to be effective. Furthermore, it is said to be effective for heart and brain central nervous system diseases such as hypertension, hypercholesterolemia, arteriosclerosis, and cranial nerve weakness.

本発明に使用する「サラシア」とは、インド、スリランカから東南アジアにかけて分布するニシキギ科のつる性植物で、現地では古くから薬用や食べ物として利用されており、インド伝承医学「アーユル・ヴェーダ」では、糖尿病や肥満の予防や治療に使われていた。 `` Salasia '' used in the present invention is a vine plant belonging to the family Nymphalidae distributed from India, Sri Lanka to Southeast Asia, and has been used locally as medicinal and food from the ancient times.In the Indian traditional medicine `` Ayurveda '', It was used to prevent and treat diabetes and obesity.

本発明に使用する「オオウメガサソウ」とは、北アメリカのケベック州からジョウジア州とヨーロッパ、日本では茨城県以北の太平洋側、北海道に分布し、アメリカインディアンの間に広く愛用され膀胱結石の薬用に供されている。 "Omegasasou" used in the present invention is distributed from Quebec to North America and Europe in North America, in the Pacific side north of Ibaraki Prefecture in Japan, in Hokkaido, and is widely used by American Indians for medicinal use of bladder stones It is offered to.

なお、ナツメ(Ziziphus
zizyphus(Rhamnaceae))の果核(酸棗仁)、MACJONG(Sterculia lychnophora)の果実(Malva nuts)、カボチャ(Cucurbita moschata(Cucurbitaceae))の種子、トチュウ(Eucommia
ulmoildes(Eucommiaceae))の葉、サラシア(Salacia oblonga(Celastraceae))の根、オオウメガサソウ(Chimaphila umbellata (L.) W. Barton(Pyrolaceae))の葉から得られる植物抽出物は、抽出溶媒としては、水やエタノールなどの各種極性有機溶媒及びそれらの混液を用いることができる。抽出物の精製は、様々な方法が用いられるが、活性炭、スチレン−ジビニルベンゼン系合成吸着剤(HP−20:三菱化成社製)やオクタデシルシラン処理シリカ(Chromatorex ODS:富士シリシア化学製)により吸着させ、適当な溶媒で溶出する方法が簡便でかつ実用的である。
In addition, jujube (Ziziphus
Fruit core of zizyphus (Rhamnaceae), MACJONG (Sterculia lychnophora) fruit (Malva nuts), pumpkin (Cucurbita moschata (Cucurbitaceae)) seed, Eucommia
The plant extract obtained from leaves of ulmoildes (Eucommiaceae), roots of Salacia (Salacia oblonga (Celastraceae)) and leaves of Chimaphila umbellata (L.) W. Barton (Pyrolaceae)) Various polar organic solvents such as water and ethanol and mixtures thereof can be used. Various methods are used to purify the extract, but it is adsorbed by activated carbon, styrene-divinylbenzene synthetic adsorbent (HP-20: manufactured by Mitsubishi Kasei) or octadecylsilane-treated silica (Chromatorex ODS: manufactured by Fuji Silysia Chemical). The method of eluting with an appropriate solvent is simple and practical.

本発明のメイラード反応阻害剤は、常法に従い、必須成分であるナツメ(Ziziphus zizyphus(Rhamnaceae))の果核(酸棗仁)、MACJONG(Sterculia lychnophora)の果実(Malva nuts)、カボチャ(Cucurbita moschata(Cucurbitaceae))の種子、トチュウ(Eucommia
ulmoildes(Eucommiaceae))の葉、サラシア(Salacia oblonga(Celastraceae))の根、オオウメガサソウ(Chimaphila umbellata (L.) W. Barton(Pyrolaceae))の葉から得られる植物抽出物を通常の製剤用基剤に配合して調製することができる。
The Maillard reaction inhibitor of the present invention is prepared in accordance with a conventional method, such as the essential component of jujube (Ziziphus zizyphus (Rhamnaceae)), the fruit nucleus (acidic acid), MACJONG (Sterculia lychnophora), fruit (Malva nuts), and pumpkin (Cucurbita moschata (Cucurbita moschata). Cucurbitaceae)) seed, Eucommia
Plant extracts obtained from leaves of ulmoildes (Eucommiaceae), roots of Salacia oblonga (Celastraceae), leaves of chimaphila umbellata (L.) W. Barton (Pyrolaceae)) It can mix | blend and prepare.

本発明のメイラード反応阻害剤及びそれを含有する皮膚外用剤又は飲食品におけるナツメ(Ziziphus zizyphus(Rhamnaceae))の果核(酸棗仁)、MACJONG(Sterculia lychnophora)の果実(Malva nuts)、カボチャ(Cucurbita moschata(Cucurbitaceae))の種子、トチュウ(Eucommia
ulmoildes(Eucommiaceae))の葉、サラシア(Salacia oblonga(Celastraceae))の根、オオウメガサソウ(Chimaphila umbellata (L.) W. Barton(Pyrolaceae))の葉から得られる植物抽出物の含有量は、乾燥固形分として好ましくは0.0001〜10重量%(以下、特に記載のあるもの以外は重量%を単に%で示す)、より好ましくは0.01〜5%である。抽出液を使用する場合は、溶質である乾燥固形分の含有量が上記範囲内であれば、その抽出液濃度等は何ら限定されるものではない。
Maillard reaction inhibitor of the present invention and topical skin preparation containing the same (Ziziphus zizyphus (Rhamnaceae)) fruit nuclei (acidic acid), MACJONG (Sterculia lychnophora) fruit (Malva nuts), pumpkin (Cucurbita) Seeds of moschata (Cucurbitaceae), Eucommia
The content of plant extracts obtained from leaves of ulmoildes (Eucommiaceae), roots of Salacia oblonga (Celastraceae) and leaves of Chimaphila umbellata (L.) W. Barton (Pyrolaceae) Preferably, the content is 0.0001 to 10% by weight (hereinafter, except for those particularly described, the weight% is simply indicated by%), more preferably 0.01 to 5%. When the extract is used, the concentration of the extract is not limited as long as the content of the dry solid content as the solute is within the above range.

尚、本発明において、前記ナツメ(Ziziphus
zizyphus(Rhamnaceae))の果核(酸棗仁)、MACJONG(Sterculia lychnophora)の果実(Malva nuts)、カボチャ(Cucurbita moschata(Cucurbitaceae))の種子、トチュウ(Eucommia
ulmoildes(Eucommiaceae))の葉、サラシア(Salacia oblonga(Celastraceae))の根、オオウメガサソウ(Chimaphila umbellata (L.) W. Barton(Pyrolaceae))の葉から得られる植物抽出物を配合する皮膚外用剤の製剤化に際して、使用の態様に応じて選択することができ、例えば、精製水、低級アルコール、多価アルコール、高級アルコール、油脂、ロウ、シリコン類、粉体、界面活性剤、水溶性高分子、植物エキス、紫外線吸収剤、増粘剤、色素、防腐剤、香料、酸化防止剤等を用いることができる。同様に、飲食品の製剤化に際して、通常使用される充填剤、増量剤、結合剤、崩壊剤、界面活性剤、滑沢剤などの稀釈剤または賦形剤を用いることができる。このように、本発明の効果を損なわない範囲内で、医薬部外品、化粧品、飲食品などの製剤に使用される成分や添加剤を併用して製造することができ、製剤中への含有量は、特に規定しない。
In the present invention, the jujube (Ziziphus
Fruit core of zizyphus (Rhamnaceae), MACJONG (Sterculia lychnophora) fruit (Malva nuts), pumpkin (Cucurbita moschata (Cucurbitaceae)) seed, Eucommia
A topical skin preparation containing a plant extract obtained from leaves of ulmoildes (Eucommiaceae), roots of Salacia oblonga (Celastraceae), and leaves of Chimaphila umbellata (L.) W. Barton (Pyrolaceae) Upon formulation, it can be selected according to the mode of use, such as purified water, lower alcohol, polyhydric alcohol, higher alcohol, fats and oils, waxes, silicones, powders, surfactants, water-soluble polymers, Plant extracts, ultraviolet absorbers, thickeners, pigments, preservatives, fragrances, antioxidants, and the like can be used. Similarly, diluents or excipients such as fillers, fillers, binders, disintegrants, surfactants, lubricants and the like that are commonly used can be used in formulating food and drink. Thus, within the range that does not impair the effects of the present invention, it can be produced by using components and additives used in preparations such as quasi-drugs, cosmetics, foods and drinks, and contained in the preparations. The amount is not particularly specified.

又、本発明のメイラード反応阻害剤、更に皮膚外用剤又は飲食品の剤型は任意であり、アンプル状、カプセル状、粉末状、顆粒状、丸剤、錠剤状、固形状、液状、ゲル状、気泡状、乳液状、クリーム状、軟膏状、シート状などの医薬部外品、化粧品又は飲食品に配合して用いることができる。 In addition, the Maillard reaction inhibitor of the present invention, and the dosage form of an external preparation for skin or food and drink are arbitrary, ampoules, capsules, powders, granules, pills, tablets, solids, liquids, gels It can be used by blending into quasi-drugs such as foam, emulsion, cream, ointment, and sheet, cosmetics or foods.

具体的には、例えば、皮膚外用剤として、化粧水、乳液、クリーム、軟膏、ローション、オイル、パックなどの基礎化粧料、洗顔料や皮膚洗浄料、ファンデーション、白粉、おしろい、口紅、頬紅、アイシャドウ、アイライナー、マスカラ、眉墨、まつ毛などのメークアップ化粧料などである。一般的な飲食品としては、サプリメント、ドリンク、シリアル、粉末飲料、ゼリー、ビスケット、飴、ガムなどへの使用も可能である。 Specifically, for example, skin external preparations such as lotions, emulsions, creams, ointments, lotions, oils, packs, and other basic cosmetics, facial cleansers and skin cleansers, foundations, white powder, funny, lipsticks, blushers, eye Makeup cosmetics such as shadow, eyeliner, mascara, eyebrows, and eyelashes. Common foods and drinks can be used for supplements, drinks, cereals, powdered drinks, jelly, biscuits, strawberries, gums, and the like.

以下に参考例、試験例及び実施例を挙げ、本発明について更に説明する。なお、これらは本発明を何ら限定するものではない。 The present invention will be further described with reference examples, test examples and examples. In addition, these do not limit this invention at all.

「製造例1」
ナツメの果核(酸棗仁)、MACJONGの果実(Malva nuts)、カボチャの種子、トチュウの葉、サラシアの根、オオウメガサソウの葉を乾燥させる。この乾燥物10重量部に水または50%(v/v)エタノール水溶液150重量部を加え、水の場合は60℃で3時間、50%エタノールの場合は室温で時々攪拌しながら3日間抽出し、濾過して、溶媒を留去し、抽出物を得た。これらを試料として試験例1の方法により、メイラード反応阻害能を測定した。水抽出物の結果を表1に50%エタノール抽出物の結果を表2に示した。
"Production Example 1"
Dried fruit kernels (acid vines), MACJONG fruits (Malva nuts), pumpkin seeds, eucommia leaves, salacia roots, and giant cassava leaves. To 10 parts by weight of the dried product, 150 parts by weight of water or a 50% (v / v) aqueous ethanol solution is added. Extraction is performed for 3 days at 60 ° C. for water for 3 hours and for 50% ethanol at room temperature with occasional stirring for 3 days. The mixture was filtered and the solvent was distilled off to obtain an extract. The Maillard reaction inhibition ability was measured by the method of Test Example 1 using these as samples. The results of the water extract are shown in Table 1, and the results of the 50% ethanol extract are shown in Table 2.

「試験方法及び評価方法」
a)試料本発明の製造例1で得られた抽出液を用い、試験に供した。尚、ブランクとして50%エタノール溶液、陽性対照として20mMのアミノグアニジンを同様の条件で調製し、試験に用いた。
b)ペントシジン(pentosidine)の生成抑制作用の測定試料溶液10μLに50mM Ribose、50mM Lysine、50mM Arginine、100mM Na2HPO4(pH7.4)、H2Oを各100μL加え、60℃、24時間ヒートブロック上でインキュベートし、反応終了後、反応溶液100μLにHO 400μLを加え、高速液体クロマトグラフィーにてPentosidine生成量を測定した。
<高速液体クロマトグラフィー測定条件>
溶媒は、アセトニトリル:TFA:HO=3:0.1:96.9を使用。流速は1mL/min、カラム温度は室温、励起波長を335nmとし測定波長を380nmとする。インジェクション量は10μLで行う。尚、ペントシジン(pentosidine)標品は、Monnieの方法に基づいて調整し、各種機器スペクトルデータにより確認した。それを用いて高速液体クロマトグラム上のピークがペントシジン(pentosidine)であることを確認した。
"Test method and evaluation method"
a) Sample The extract obtained in Production Example 1 of the present invention was used for the test. A blank 50% ethanol solution and a 20 mM aminoguanidine as a positive control were prepared under the same conditions and used in the test.
b) Measurement of Pentosidine Production Suppressing Action Add 10 μL of 50 mM Ribose, 50 mM Lysine, 50 mM Arginine, 100 mM Na 2 HPO 4 (pH 7.4) and H 2 O to 10 μL of the sample solution, and heat at 60 ° C. for 24 hours. After incubation on the block and completion of the reaction, 400 μL of H 2 O was added to 100 μL of the reaction solution, and the amount of Pentoside produced was measured by high performance liquid chromatography.
<High-performance liquid chromatography measurement conditions>
The solvent used is acetonitrile: TFA: H 2 O = 3: 0.1: 96.9. The flow rate is 1 mL / min, the column temperature is room temperature, the excitation wavelength is 335 nm, and the measurement wavelength is 380 nm. The injection volume is 10 μL. The pentosidine preparation was adjusted based on the method of Monnie and confirmed with various instrument spectral data. Using this, it was confirmed that the peak on the high performance liquid chromatogram was pentosidine.

Figure 2007254345
Figure 2007254345

表1の結果から明らかなように、ナツメ(Ziziphus zizyphus(Rhamnaceae))の果核(酸棗仁)、MACJONG(Sterculia lychnophora)の果実(Malva nuts)、カボチャ(Cucurbita moschata(Cucurbitaceae))の種子、トチュウ(Eucommia
ulmoildes(Eucommiaceae))の葉、サラシア(Salacia oblonga(Celastraceae))の根、オオウメガサソウ(Chimaphila umbellata (L.) W. Barton(Pyrolaceae))の葉の抽出物は、メイラード反応の公知の阻害剤であるアミノグアニジンと比較して著しく高いメイラード反応によるペントシジン生成抑制効果が認められた。
As can be seen from the results in Table 1, the fruit kernel (acid vine) of the jujube (Ziziphus zizyphus (Rhamnaceae)), the fruit (Malva nuts) of the MACJONG (Sterculia lychnophora), the seed of the pumpkin (Cucurbita moschata (Cucurbitaceae)) (Eucommia
Extracts from leaves of ulmoildes (Eucommiaceae), roots of Salacia oblonga (Celastraceae), and leaves of Chimaphila umbellata (L.) W. Barton (Pyrolaceae) are known inhibitors of the Maillard reaction. Compared with certain aminoguanidines, the pentosidine production inhibitory effect by the Maillard reaction was remarkably high.

以下に本発明の皮膚外用剤または飲食品の処方例を挙げる。 Examples of the external preparation for skin or food and drink of the present invention will be given below.

〔化粧水〕
(成分名) (質量%)
ナツメ果核(酸棗仁)水抽出物 5.0
グリセリン 5.0
ポリオキシエチレンソルビタンモノラウレート(20E.0) 1.5
エタノール 8.0
クエン酸トリエチル 2.0
防腐剤・酸化防止剤 適量
精製水 残部
[Lotion]
(Ingredient name) (mass%)
Jujube Fruit Nucleate (Acetic Acid) Water Extract 5.0
Glycerin 5.0
Polyoxyethylene sorbitan monolaurate (20E.0) 1.5
Ethanol 8.0
Triethyl citrate 2.0
Preservative / Antioxidant
Purified water balance

〔化粧用クリーム〕
(成分名) (質量%)
トチュウ葉50%エタノール抽出物 0.5
ミツロウ 2.0
ステアリルアルコール 5.0
ステアリン酸 8.0
スクワラン 10.0
自己乳化型グリセリルモノステアレート 3.0
ポリオキシエチレンセチルエーテル(20E.0) 1.0
グリセリン 5.0
水酸化カリウム 0.3
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
[Cosmetic cream]
(Ingredient name) (mass%)
Eucommia leaf 50% ethanol extract 0.5
Beeswax 2.0
Stearyl alcohol 5.0
Stearic acid 8.0
Squalane 10.0
Self-emulsifying glyceryl monostearate 3.0
Polyoxyethylene cetyl ether (20E.0) 1.0
Glycerin 5.0
Potassium hydroxide 0.3
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water

〔乳液〕
(成分名) (質量%)
カボチャ種子水抽出物 0.01
スクワラン 8.0
ワセリン 2.0
ミツロウ 0.5
ソルビタンセスキオレエート 0.8
ポリオキシエチレンオレイルエーテル(20E.0) 1.2
カルボキシビニルポリマー 0.2
グリセリン 1.5
水酸化カリウム 0.1
エタノール 7.0
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
[Emulsion]
(Ingredient name) (mass%)
Pumpkin seed water extract 0.01
Squalane 8.0
Vaseline 2.0
Beeslow 0.5
Sorbitan sesquioleate 0.8
Polyoxyethylene oleyl ether (20E.0) 1.2
Carboxyvinyl polymer 0.2
Glycerin 1.5
Potassium hydroxide 0.1
Ethanol 7.0
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water

〔パック剤〕
(成分名) (質量%)
サラシア根水抽出物 0.001
酢酸ビニル樹脂エマルジョン 15.0
ポリビニルアルコール 10.0
ホホバ油 3.0
グリセリン 5.0
酸化チタン 8.0
カオリン 7.0
エタノール 5.0
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
[Packing agent]
(Ingredient name) (mass%)
Salacia root extract 0.001
Vinyl acetate resin emulsion 15.0
Polyvinyl alcohol 10.0
Jojoba oil 3.0
Glycerin 5.0
Titanium oxide 8.0
Kaolin 7.0
Ethanol 5.0
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water

〔軟膏〕
(成分名) (質量%)
オオウメガサソウ葉50%エタノール抽出物 0.0001
酢酸トコフェロール 0.5
パラジメチルアミノ安息香酸オクチル 4.0
ブチルメトキシベンゾイルメタン 4.0
ステアリルアルコール 18.0
モクロウ 20.0
グリセリンモノステアリン酸エステル 0.3
ワセリン 33.0
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
〔ointment〕
(Ingredient name) (mass%)
Persian leaf 50% ethanol extract 0.0001
Tocopherol acetate 0.5
Octyl paradimethylaminobenzoate 4.0
Butylmethoxybenzoylmethane 4.0
Stearyl alcohol 18.0
Owl 20.0
Glycerin monostearate 0.3
Vaseline 33.0
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water

〔錠剤〕
(成分名) (質量%)
ナツメ果核(酸棗仁)50%エタノール抽出物 1.0
ショ糖脂肪酸エステル 2.0
デンプン 15.0
シェラック 1.2
乳糖 10.0
結晶セルロース 残部
〔tablet〕
(Ingredient name) (mass%)
Jujube fruit nuclei (acid vine) 50% ethanol extract 1.0
Sucrose fatty acid ester 2.0
Starch 15.0
Shellac 1.2
Lactose 10.0
Crystalline cellulose balance

〔ドリンク〕
(成分名) (質量%)
MACJONG果実水抽出物
10.0
乳酸カルシウム 2.0
塩化マグネシウム 0.1
ビタミンミックス 0.1
酸味料・香料 適量
果糖ブドウ糖液糖 適量
保存剤 適量
水 残部
〔Drink〕
(Ingredient name) (mass%)
MACJONG fruit water extract
10.0
Calcium lactate 2.0
Magnesium chloride 0.1
Vitamin mix 0.1
Acidulant / flavoring Appropriate amount of fructose, glucose liquid sugar Appropriate amount

〔ゼリー〕
(成分名) (質量%)
トチュウ葉水抽出物 2.0
ゲル化剤 3.5
砂糖 50.0
果汁 2.0
香料 適量
酸味料・甘味料 適量
水 残部
〔jelly〕
(Ingredient name) (mass%)
Eucommia leaf water extract 2.0
Gelling agent 3.5
Sugar 50.0
Fruit juice 2.0
Perfume Appropriate amount of acidulant / sweetener Appropriate amount of water Balance

〔キャンディー〕
(成分名) (質量%)
サラシア根水抽出物 1.0
砂糖 35.0
果汁 2.0
酸味料 0.5
香料 0.5
水飴 残部
[Candy]
(Ingredient name) (mass%)
Salacia root extract 1.0
Sugar 35.0
Fruit juice 2.0
Acidulant 0.5
Fragrance 0.5
Minamata remainder

〔ガム〕
(成分名) (質量%)
ナツメ果核(酸棗仁)50%エタノール抽出物 3.0
軟化材 4.0
色素 3.0
香料 3.0
ガムベース 残部
[Gum]
(Ingredient name) (mass%)
Jujube fruit nucleus (acid soy sauce) 50% ethanol extract 3.0
Softening material 4.0
Dye 3.0
Fragrance 3.0
The rest of the gum base

本発明のナツメ(Ziziphus
zizyphus(Rhamnaceae))の果核(酸棗仁)、MACJONG(Sterculia lychnophora)の果実(Malva nuts)、カボチャ(Cucurbita moschata(Cucurbitaceae))の種子、トチュウ(Eucommia
ulmoildes(Eucommiaceae))の葉、サラシア(Salacia oblonga(Celastraceae))の根、オオウメガサソウ(Chimaphila umbellata (L.) W. Barton(Pyrolaceae))の葉の抽出物は、皮膚に対しては皮膚の硬化、しわ形成、はり喪失や、肌のくすみを抑制して、優れた皮膚老化防止効果、美肌効果を示す。
また、生体内で生成するメイラード反応を抑えることにより、高血糖を起因とする合併症(糖尿病神経障害、糖尿病網膜症、糖尿病腎症)や種々の病変や老化を予防することができるため、老化予防を目的とする皮膚外用剤及び飲食品に広く応用が期待できる。
Jujube (Ziziphus) of the present invention
Fruit core of zizyphus (Rhamnaceae), MACJONG (Sterculia lychnophora) fruit (Malva nuts), pumpkin (Cucurbita moschata (Cucurbitaceae)) seed, Eucommia
Extracts of leaves of ulmoildes (Eucommiaceae), roots of Salacia oblonga (Celastraceae), leaves of chimaphila umbellata (L.) W. Barton (Pyrolaceae) are hardened against the skin It suppresses wrinkle formation, loss of skin, and dull skin, and exhibits excellent skin aging prevention and skin beautifying effects.
In addition, by suppressing the Maillard reaction generated in the body, it is possible to prevent complications (diabetic neuropathy, diabetic retinopathy, diabetic nephropathy) and various lesions and aging caused by hyperglycemia. Wide application can be expected for external preparations for skin and foods and drinks for the purpose of prevention.

Claims (4)

ナツメ(Ziziphus
zizyphus(Rhamnaceae))の果核(酸棗仁)、MACJONG(Sterculia lychnophora)の果実(Malva nuts)、カボチャ(Cucurbita moschata(Cucurbitaceae))の種子、トチュウ(Eucommia
ulmoildes(Eucommiaceae))の葉、サラシア(Salacia oblonga(Celastraceae))の根、オオウメガサソウ(Chimaphila umbellata (L.) W. Barton(Pyrolaceae))の葉から選ばれる1種又は2種以上の植物抽出物を含有することを特徴とするメイラード反応阻害剤。
Jujube (Ziziphus
Fruit core of zizyphus (Rhamnaceae), MACJONG (Sterculia lychnophora) fruit (Malva nuts), pumpkin (Cucurbita moschata (Cucurbitaceae)) seed, Eucommia
One or more plant extracts selected from leaves of ulmoildes (Eucommiaceae), roots of Salacia oblonga (Celastraceae) and leaves of Chimaphila umbellata (L.) W. Barton (Pyrolaceae) Containing a Maillard reaction inhibitor.
ペントシジン生成阻害作用を有することを特徴とする請求項第1項記載のメイラード反応阻害剤。 The Maillard reaction inhibitor according to claim 1, which has a pentosidine production inhibitory action. 請求項第1項記載のメイラード反応阻害剤を含有することを特徴とする皮膚外用剤。 An external preparation for skin comprising the Maillard reaction inhibitor according to claim 1. 請求項第1項記載のメイラード反応阻害剤を含有することを特徴とする飲食品。
A food or drink comprising the Maillard reaction inhibitor according to claim 1.
JP2006080105A 2006-03-23 2006-03-23 Maillard reaction inhibitor, external preparation for skin containing the same, and food and drink Active JP5313436B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006080105A JP5313436B2 (en) 2006-03-23 2006-03-23 Maillard reaction inhibitor, external preparation for skin containing the same, and food and drink

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006080105A JP5313436B2 (en) 2006-03-23 2006-03-23 Maillard reaction inhibitor, external preparation for skin containing the same, and food and drink

Publications (2)

Publication Number Publication Date
JP2007254345A true JP2007254345A (en) 2007-10-04
JP5313436B2 JP5313436B2 (en) 2013-10-09

Family

ID=38628946

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006080105A Active JP5313436B2 (en) 2006-03-23 2006-03-23 Maillard reaction inhibitor, external preparation for skin containing the same, and food and drink

Country Status (1)

Country Link
JP (1) JP5313436B2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009072674A1 (en) * 2007-12-07 2009-06-11 Fujifilm Corporation Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
JP2009161522A (en) * 2007-12-11 2009-07-23 Hayashibara Biochem Lab Inc Inhibitor for renal dysfunction
JP2010077123A (en) * 2008-08-29 2010-04-08 Hayashikane Sangyo Kk Maillard reaction inhibitor
JP2011020947A (en) * 2009-07-15 2011-02-03 Sankensha:Kk Medicine for external use having sugar lowering effect
JP2011504885A (en) * 2007-11-30 2011-02-17 戚 郁芬 Antidepressants prepared from salmon cyclic adenosine monophosphate
CN102002072A (en) * 2010-09-30 2011-04-06 天津市食品研究所有限公司 Process for extracting flavone from date pit
JP2012046459A (en) * 2010-08-28 2012-03-08 Asama Chemical Co Ltd Composition for preventing or treating urologic disease and method for producing the same
JP2012206943A (en) * 2011-03-29 2012-10-25 Asama Chemical Co Ltd Sleep-improving agent
JP2013166713A (en) * 2012-02-14 2013-08-29 Ichimaru Pharcos Co Ltd Kinesin inhibitor
WO2013133390A1 (en) * 2012-03-08 2013-09-12 タカノ株式会社 Anti-nephropathic drug
JP2019119713A (en) * 2018-01-09 2019-07-22 共栄化学工業株式会社 External composition for skin
US10568827B2 (en) 2015-09-02 2020-02-25 Hayashibara Co., Ltd. External dermal agent for reducing yellowish dullness

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105105081A (en) * 2015-09-25 2015-12-02 天宁香料(江苏)有限公司 Preparation method of thermo-reactive red jujube flavor

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6116364B2 (en) * 1982-11-16 1986-04-30 Ichimaru Fuarukosu Kk
JPS62249908A (en) * 1986-04-21 1987-10-30 Lion Corp Crosslinking reaction inhibitor for collagen
JPH0692821A (en) * 1992-09-14 1994-04-05 Ichimaru Pharcos Co Ltd Cosmetic containing eucommia ulmoides leaf extract
JPH0820544A (en) * 1994-07-04 1996-01-23 Takasago Internatl Corp Reactive oxygen eliminator and food products and cosmetics formulated therewith
JPH08259431A (en) * 1995-03-20 1996-10-08 Kose Corp Maillard reaction inhibitor and dermal preparation for external use containing the same
JPH1017436A (en) * 1996-06-25 1998-01-20 Shiseido Co Ltd Skin preparation for external use
JPH10109924A (en) * 1996-10-03 1998-04-28 Mikimoto Pharmaceut Co Ltd Beautifying and whitening cosmetic
JP2000143437A (en) * 1998-11-09 2000-05-23 Ichimaru Pharcos Co Ltd Cosmetic composition containing huhectant vegetable extract
JP2000212059A (en) * 1999-01-22 2000-08-02 Naris Cosmetics Co Ltd Cosmetic
JP2000319122A (en) * 1999-04-30 2000-11-21 Zenzaburo Hara Cell proliferation promoting cosmetic
JP2003171225A (en) * 2001-11-30 2003-06-17 Fancl Corp COMPOSITION FOR INTEGRINalpha6beta4 PRODUCTION PROMOTION
JP2003212781A (en) * 2002-01-22 2003-07-30 Maruzen Pharmaceut Co Ltd Hyaluronic acid production promoter, skin cosmetic and food and beverage for beautification
JP2003238383A (en) * 2002-02-14 2003-08-27 Fancl Corp Skin care preparation
JP2003334032A (en) * 2002-03-12 2003-11-25 Suehito Yamagami Health supplement food having ameliorating action for somnipathy
JP2004149729A (en) * 2002-10-31 2004-05-27 Ikeda Shokken Kk Antioxidant
JP2004168770A (en) * 2002-10-31 2004-06-17 Ikeda Shokken Kk Enzyme inhibitor
JP2004250445A (en) * 2003-01-31 2004-09-09 Yakult Honsha Co Ltd Glycation inhibitor and its use
JP2005029556A (en) * 2002-10-31 2005-02-03 Ikeda Shokken Kk Skin aging-preventing agent
JP2005035911A (en) * 2003-07-18 2005-02-10 Arkray Inc Maillard reaction inhibitor
JP2005194246A (en) * 2004-01-09 2005-07-21 Ichimaru Pharcos Co Ltd NF-kappaB ACTIVATION INHIBITOR

Patent Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6116364B2 (en) * 1982-11-16 1986-04-30 Ichimaru Fuarukosu Kk
JPS62249908A (en) * 1986-04-21 1987-10-30 Lion Corp Crosslinking reaction inhibitor for collagen
JPH0692821A (en) * 1992-09-14 1994-04-05 Ichimaru Pharcos Co Ltd Cosmetic containing eucommia ulmoides leaf extract
JPH0820544A (en) * 1994-07-04 1996-01-23 Takasago Internatl Corp Reactive oxygen eliminator and food products and cosmetics formulated therewith
JPH08259431A (en) * 1995-03-20 1996-10-08 Kose Corp Maillard reaction inhibitor and dermal preparation for external use containing the same
JPH1017436A (en) * 1996-06-25 1998-01-20 Shiseido Co Ltd Skin preparation for external use
JPH10109924A (en) * 1996-10-03 1998-04-28 Mikimoto Pharmaceut Co Ltd Beautifying and whitening cosmetic
JP2000143437A (en) * 1998-11-09 2000-05-23 Ichimaru Pharcos Co Ltd Cosmetic composition containing huhectant vegetable extract
JP2000212059A (en) * 1999-01-22 2000-08-02 Naris Cosmetics Co Ltd Cosmetic
JP2000319122A (en) * 1999-04-30 2000-11-21 Zenzaburo Hara Cell proliferation promoting cosmetic
JP2003171225A (en) * 2001-11-30 2003-06-17 Fancl Corp COMPOSITION FOR INTEGRINalpha6beta4 PRODUCTION PROMOTION
JP2003212781A (en) * 2002-01-22 2003-07-30 Maruzen Pharmaceut Co Ltd Hyaluronic acid production promoter, skin cosmetic and food and beverage for beautification
JP2003238383A (en) * 2002-02-14 2003-08-27 Fancl Corp Skin care preparation
JP2003334032A (en) * 2002-03-12 2003-11-25 Suehito Yamagami Health supplement food having ameliorating action for somnipathy
JP2004149729A (en) * 2002-10-31 2004-05-27 Ikeda Shokken Kk Antioxidant
JP2004168770A (en) * 2002-10-31 2004-06-17 Ikeda Shokken Kk Enzyme inhibitor
JP2005029556A (en) * 2002-10-31 2005-02-03 Ikeda Shokken Kk Skin aging-preventing agent
JP2004250445A (en) * 2003-01-31 2004-09-09 Yakult Honsha Co Ltd Glycation inhibitor and its use
JP2005035911A (en) * 2003-07-18 2005-02-10 Arkray Inc Maillard reaction inhibitor
JP2005194246A (en) * 2004-01-09 2005-07-21 Ichimaru Pharcos Co Ltd NF-kappaB ACTIVATION INHIBITOR

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011504885A (en) * 2007-11-30 2011-02-17 戚 郁芬 Antidepressants prepared from salmon cyclic adenosine monophosphate
WO2009072674A1 (en) * 2007-12-07 2009-06-11 Fujifilm Corporation Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
JP2009161522A (en) * 2007-12-11 2009-07-23 Hayashibara Biochem Lab Inc Inhibitor for renal dysfunction
JP2010077123A (en) * 2008-08-29 2010-04-08 Hayashikane Sangyo Kk Maillard reaction inhibitor
JP2014094964A (en) * 2008-08-29 2014-05-22 Hayashikane Sangyo Kk Maillard reaction inhibitor
JP2011020947A (en) * 2009-07-15 2011-02-03 Sankensha:Kk Medicine for external use having sugar lowering effect
JP2012046459A (en) * 2010-08-28 2012-03-08 Asama Chemical Co Ltd Composition for preventing or treating urologic disease and method for producing the same
CN102002072A (en) * 2010-09-30 2011-04-06 天津市食品研究所有限公司 Process for extracting flavone from date pit
JP2012206943A (en) * 2011-03-29 2012-10-25 Asama Chemical Co Ltd Sleep-improving agent
JP2013166713A (en) * 2012-02-14 2013-08-29 Ichimaru Pharcos Co Ltd Kinesin inhibitor
WO2013133390A1 (en) * 2012-03-08 2013-09-12 タカノ株式会社 Anti-nephropathic drug
JPWO2013133390A1 (en) * 2012-03-08 2015-07-30 タカノ株式会社 Antinephrotic drugs
US10568827B2 (en) 2015-09-02 2020-02-25 Hayashibara Co., Ltd. External dermal agent for reducing yellowish dullness
JP2019119713A (en) * 2018-01-09 2019-07-22 共栄化学工業株式会社 External composition for skin
JP7246605B2 (en) 2018-01-09 2023-03-28 共栄化学工業株式会社 Skin topical composition

Also Published As

Publication number Publication date
JP5313436B2 (en) 2013-10-09

Similar Documents

Publication Publication Date Title
JP5313436B2 (en) Maillard reaction inhibitor, external preparation for skin containing the same, and food and drink
JP6674001B2 (en) Maillard reaction inhibitor
WO2013100105A1 (en) Maillard reaction inhibitor
JP5122752B2 (en) Maillard reaction inhibitor
CN108697685A (en) Containing moracin, Phellinus copper G or the root bark of white mulberry, the prevention of muscle disease and treatment is used or muscular function improvement composition
JP2006306804A (en) Wrinkle formation inhibitor
JP2007261987A (en) Tyrosinase inhibitor, process for its preparation and its use
JP2020033380A (en) Anti-aging agent
JP3968405B2 (en) Antiallergic agent
KR101292837B1 (en) Composition for skin wrinkle improvement comprising extracts of Junglans mandshurica MAXIM as an active ingredient
JP2002003390A (en) Fibroblast growth agent, food and drink for beauty culture and skin cosmetic
WO2011043212A1 (en) Ceramide production enhancer and moisturizing agent
JP2011195531A (en) Protein glycation inhibitor
JP2004026719A (en) Antiobestic composition comprising extract of astringent coat of peanut as active ingredient
JP6059510B2 (en) Ceramide production promoter
US20080138384A1 (en) Oral hair growth stimulants comprising orthosiphon
KR20170124426A (en) Composition for prevention and treatment of muscular disorders or improvement of muscular functions comprising extract of Amaranthus spp. or grain cereals
JP2007197360A (en) Melanogenesis inhibitor, active oxygen scavenger and composition containing the scavenger
JP2002302452A (en) Histamine separation inhibitor, cyclic amp phosphodiesterase inhibitor, active oxygen scavenger and radical scavenger
JP2011195530A (en) Protein glycation inhibitor
JP2005220100A (en) Anti-ageing agent, platelet aggregation inhibitor, antioxidant, anti-allergic agent, skin cosmetic, and food and drink
JP2008081441A (en) Protease activity promoter
JP3900977B2 (en) Skin cosmetics and beauty food and drink
JP2004161678A (en) Anti-inflammatory agent and cyclic amp phosphodiesterase inhibitor
JPH09278667A (en) Composition having ability to scavenge active oxygen

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120508

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120706

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130507

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130702

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130704

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5313436

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250